649 top medical experts on Pneumococcal Pneumonia across 59 countries and 38 U.S. states, including 533 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Pneumococcal Pneumonia: A febrile disease caused by streptococcus pneumoniae.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Pneumococcal Infections (4,236), Bacterial Pneumonia (3,165).
  4. Clinical Trials ClinicalTrials.gov : at least 115 including 5 Active, 77 Completed, 12 Recruiting


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Musher, Daniel M   Internal Medicine   ClinicalTrials.gov Google Publications
    Dept of Medicine, Baylor College of Medicine, Houston, TX, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial  Review 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $3,034.7, including $3,034.7 from  Merck Sharp & Dohme Corporation
    Subjects: Pneumonia, Pneumococcal; Anti-Bacterial Agents; Community-Acquired Infections; Bacteremia; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Macrolides
    Categories: Epidemiology; Therapeutic Use; Drug Therapy; Blood; Pathology; Administration & Dosage
    The obesity paradox in community-acquired bacterial pneumonia. (2011)
    Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults. (2011)

  2. Scott, Daniel A   Infectious Disease   Google Publications
    Vaccine Research and Development, Pfizer, Inc., Collegeville, PA, United States.
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Subjects: Pneumonia, Pneumococcal; Pneumococcal Vaccines; Streptococcus pneumoniae; Community-Acquired Infections; Immunization, Secondary; Antibodies, Bacterial
    Categories: Prevention & Control; Immunology; Administration & Dosage; Epidemiology; Adverse Effects; Blood
    Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. (2015)
    Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults. (2019)

  3. Jackson, Lisa A   Public Health & General Preventive Medicine   Google Publications
    The Group Health Research Institute, Group Health, Seattle, WA, USA.
    Physician  Highly Cited  Clinical Trial 
    Subjects: Pneumonia, Pneumococcal; Immunization, Secondary; Streptococcus pneumoniae
    Categories: Prevention & Control; Immunology
    Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults. (2013)
    Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. (2013)

  4. Wunderink, Richard G   Pulmonary Disease  Google Publications
    Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Top Hospital
    Physician 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 86.9/100
    Disclosed payments in 2021 from 9 biomedical companies, totalling $32,393.33, including $11,550 from  PFIZER INC.
    Subjects: Community-Acquired Infections; Pneumonia, Pneumococcal; Antigens, Bacterial; Bacteremia; Hospitalization; Legionnaires Disease
    Categories: Genetics; Diagnosis; Epidemiology; Immunology; Microbiology; Statistics & Numerical Data
    Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia. (2019)
    Pneumococcal and Legionella Urinary Antigen Tests in Community-acquired Pneumonia: Prospective Evaluation of Indications for Testing. (2019)

  5. Malley, Richard   Pediatric Infectious Diseases  Google Publications
    Division of Infectious Diseases, Boston Childrens Hospital, Boston Massachusetts, USA.
    Physician 
    Disclosed payments from biomedical company (Merck Sharp & Dohme Corporation) in 2021 for $1,312.5
    Subjects: Pneumonia, Pneumococcal; Streptococcus pneumoniae; CD4-Positive T-Lymphocytes; Immunity, Heterologous; Lung; Pneumococcal Vaccines
    Categories: Immunology; Genetics; Physiology; Prevention & Control
    Next generation pneumococcal vaccines. (2011)
    Regionally compartmentalized resident memory T cells mediate naturally acquired protection against pneumococcal pneumonia. (2018)

  6. Shapiro, Eugene D   Pediatrics  Google Publications
    Department of Epidemiology of Microbial Diseases; Yale School of Public Health; New Haven, CT USA; Department of Pediatrics; Yale University School of Medicine and Department of Investigative Medicine; Yale Graduate School of Arts and Sciences; New Haven, CT USA. Top Hospital
    Physician 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $4,475, including $2,975 from  PFIZER INC.
    Subjects: Pneumonia, Pneumococcal; Pneumococcal Vaccines; Vaccination; Vaccines, Conjugate
    Categories: Immunology; Prevention & Control; Economics
    Pneumococcal conjugate vaccines for adults: reasons for optimism and for caution. (2014)
    Prevention of pneumococcal infection with vaccines: an evolving story. (2012)

  7. Bennett, Nancy M   Internal Medicine  Google Publications
    Department of Medicine and Center for Community Health, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States.
    Physician 
    Disclosed payments from biomedical company (AI Therapeutics, Inc.) in 2021 for $2,000
    Subjects: Pneumonia, Pneumococcal; Health Policy; Influenza, Human; Pneumococcal Vaccines; African Americans; Haemophilus Infections
    Categories: Prevention & Control; Epidemiology; Standards; Administration & Dosage; Ethnology; Isolation & Purification
    Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines. (2015)
    Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults. (2010)

  8. Niederman, Michael S   Pulmonary Disease  Google Publications
    Division of Pulmonary and Critical Care Medicine, Weill Cornell Medical College, New York Presbyterian/Weill Cornell Medical Center, New York, NY.
    Physician  Clinical Trial 
    Disclosed payments in 2021 from 20 biomedical companies, totalling $56,599.4, including $17,463 from  Merck Sharp & Dohme Corporation
    Subjects: Pneumonia, Pneumococcal; Bacteremia; Community-Acquired Infections; Macrolides; Anti-Bacterial Agents; Drug Resistance, Microbial
    Categories: Epidemiology; Therapeutic Use; Drug Therapy; Isolation & Purification; Pharmacology; Prevention & Control
    Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. (2010)
    Effect of Combined β-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired Pneumonia. (2019)

  9. Kobzik, Lester   Anatomic Pathology   Google Publications
    Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
    Physician 
    Relevant US NIH Grant Funding: $970,844 over the last 5 years
    Subjects: Pneumonia, Pneumococcal; Gelsolin; Macrophages, Alveolar; Nitric Oxide Synthase Type III; Immunologic Factors; Lung
    Categories: Immunology; Administration & Dosage; Enzymology; Drug Therapy; Metabolism; Microbiology
    Plasma gelsolin improves lung host defense against pneumonia by enhancing macrophage NOS3 function. (2015)
    Female resistance to pneumonia identifies lung macrophage nitric oxide synthase-3 as a therapeutic target. (2014)

  10. Piantadosi, Claude A   Critical Care Medicine  Google Publications
    Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, North Carolina. Top Hospital
    Physician 
    Subjects: Pneumonia, Pneumococcal; Acute Lung Injury; Carbon Monoxide; Primates; Disease Models, Animal; Hemofiltration
    Categories: Therapy; Administration & Dosage; Blood; Immunology; Microbiology; Chemistry
    The Regulation of Proresolving Lipid Mediator Profiles in Baboon Pneumonia by Inhaled Carbon Monoxide. (2015)
    Effects of inhaled CO administration on acute lung injury in baboons with pneumococcal pneumonia. (2015)

  11. Woods, Christopher W   Infectious Disease  Google Publications
    Durham Department of Veterans Affairs Medical Center, Durham, North Carolina.
    Physician 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $4,125, including $4,125 from  Regeneron Pharmaceuticals, Inc.
    Subjects: Pneumonia, Pneumococcal; Primates; Disease Models, Animal; Hemofiltration; Heparin; Pneumococcal Vaccines
    Categories: Immunology; Microbiology; Therapy; Administration & Dosage; Chemistry; Metabolism
    Changes in childhood pneumonia and infant mortality rates following introduction of the 13-valent pneumococcal conjugate vaccine in Nicaragua. (2014)
    Development of a novel preclinical model of pneumococcal pneumonia in nonhuman primates. (2014)

  12. Karron, Ruth A   Diagnostic Radiology  Google Publications
    Department of International Health, Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
    Physician 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $3,002.76, including $1,800 from  Moderna TX, Inc.
    Subjects: Pneumonia, Pneumococcal; Streptococcus pneumoniae; DNA, Bacterial; Bacterial Load; Respiratory Tract Infections
    Categories: Diagnosis; Microbiology; Blood; Isolation & Purification; Growth & Development; Physiology
    Density of Upper Respiratory Colonization With Streptococcus pneumoniae and Its Role in the Diagnosis of Pneumococcal Pneumonia Among Children Aged <5 Years in the PERCH Study. (2017)
    Detection of Pneumococcal DNA in Blood by Polymerase Chain Reaction for Diagnosing Pneumococcal Pneumonia in Young Children From Low- and Middle-Income Countries. (2017)

  13. Weinberger, Daniel M   Neurology   Google Publications
    Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
    Physician  Highly Cited  Highly Published  Review 
    Disclosed payments in 2021 from 13 biomedical companies, totalling $21,547.54, including $21,547.54 from  Sage Therapeutics, Inc.
    Subjects: Pneumonia, Pneumococcal; Pneumococcal Vaccines; Hospitalization; Influenza, Human; Respiratory Syncytial Virus Infections; Streptococcus pneumoniae
    Categories: Epidemiology; Prevention & Control; Immunology; Statistics & Numerical Data; Administration & Dosage; Microbiology
    Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. (2010)
    Association between respiratory syncytial virus activity and pneumococcal disease in infants: a time series analysis of US hospitalization data. (2015)

  14. Matthay, Michael A   Internal Medicine  Google Publications
    Cardiovascular Research Institute, University of California, San Francisco, California. Top Hospital
    Physician 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 100/100
    Disclosed payments in 2021 from 3 biomedical companies, totalling $4,900, including $4,900 from  Gilead Sciences, Inc.
    Subjects: Pneumonia, Pneumococcal; Acute Lung Injury; Docosahexaenoic Acids; Inflammation; Lipoxins; Lung Injury
    Categories: Etiology; Antagonists & Inhibitors; Drug Therapy; Complications; Drug Effects; Isolation & Purification
    Clinically relevant model of pneumococcal pneumonia, ARDS, and nonpulmonary organ dysfunction in mice. (2019)
    Inhibition of the lipoxin A4 and resolvin D1 receptor impairs host response to acute lung injury caused by pneumococcal pneumonia in mice. (2021)

  15. Santosham, Mathuram   Diagnostic Radiology  ClinicalTrials.gov Google Publications
    Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
    Physician  Clinical Trial 
    Subjects: Pneumonia, Pneumococcal; Pneumococcal Vaccines; Streptococcus pneumoniae; Community-Acquired Infections; Antibodies, Bacterial; Antigens, Bacterial
    Categories: Epidemiology; Prevention & Control; Diagnosis; Immunology; Administration & Dosage; Blood
    The worldwide impact of the seven-valent pneumococcal conjugate vaccine. (2012)
    Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities. (2012)

  16. Schaffner, William   Infectious Disease  Google Publications
    b Department of Health Policy , Vanderbilt University School of Medicine , Nashville , TN , USA.
    Physician 
    Subjects: Pneumonia, Pneumococcal; Influenza, Human; African Americans; Pneumococcal Vaccines; Cost-Benefit Analysis; Haemophilus Infections
    Categories: Ethnology; Prevention & Control; Administration & Dosage; Economics; Epidemiology; Isolation & Purification
    Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults. (2010)
    Effect of the 2009 influenza A(H1N1) pandemic on invasive pneumococcal pneumonia. (2013)

  17. Nelson, Steve   Pulmonary Disease   Google Publications
    Department of Medicine , LSU Health Sciences Center, New Orleans, LA 70112, USA.
    Physician 
    Subjects: Pneumonia, Pneumococcal; Ethanol; Alcohol Drinking; Alcoholic Intoxication; Down-Regulation; Granulocyte Colony-Stimulating Factor
    Categories: Immunology; Complications; Physiology; Drug Effects; Physiopathology; Administration & Dosage
    Alcohol suppresses the granulopoietic response to pulmonary Streptococcus pneumoniae infection with enhancement of STAT3 signaling. (2011)
    Acute alcohol intoxication impairs the hematopoietic precursor cell response to pneumococcal pneumonia. (2010)

  18. Boyd, Angela R   Obstetrics & Gynecology  Google Publications
    Department of Microbiology and Immunology, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA.
    Physician 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 58/100
    Subjects: Pneumonia, Pneumococcal; Acute Lung Injury; Aging; Anticholesteremic Agents; Cellular Senescence; Cytokines
    Categories: Immunology; Administration & Dosage; Microbiology; Pathology; Biosynthesis; Drug Therapy
    Age-related defects in TLR2 signaling diminish the cytokine response by alveolar macrophages during murine pneumococcal pneumonia. (2012)
    Cellular senescence increases expression of bacterial ligands in the lungs and is positively correlated with increased susceptibility to pneumococcal pneumonia. (2011)

  19. Kotloff, Karen L   Pediatric Infectious Diseases  Google Publications
    Division of Infectious Disease and Tropical Pediatrics, Department of Pediatrics, Center for Vaccine Development, Institute of Global Health, University of Maryland School of Medicine, Baltimore.
    Physician 
    Subjects: Pneumonia, Pneumococcal; Streptococcus pneumoniae; DNA, Bacterial; Bacterial Load; Respiratory Tract Infections
    Categories: Diagnosis; Microbiology; Blood; Isolation & Purification; Growth & Development; Physiology
    Density of Upper Respiratory Colonization With Streptococcus pneumoniae and Its Role in the Diagnosis of Pneumococcal Pneumonia Among Children Aged <5 Years in the PERCH Study. (2017)
    Detection of Pneumococcal DNA in Blood by Polymerase Chain Reaction for Diagnosing Pneumococcal Pneumonia in Young Children From Low- and Middle-Income Countries. (2017)

  20. Gotts, Jeffrey E   Internal Medicine  Google Publications
    Cardiovascular Research Institute, University of California, San Francisco, California. Top Hospital
    Physician 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 100/100
    Subjects: Pneumonia, Pneumococcal; Acute Lung Injury; Docosahexaenoic Acids; Inflammation; Lipoxins; Lung Injury
    Categories: Etiology; Antagonists & Inhibitors; Drug Therapy; Complications; Drug Effects; Isolation & Purification
    Clinically relevant model of pneumococcal pneumonia, ARDS, and nonpulmonary organ dysfunction in mice. (2019)
    Inhibition of the lipoxin A4 and resolvin D1 receptor impairs host response to acute lung injury caused by pneumococcal pneumonia in mice. (2021)

Note:
  1. These experts have limited publications on this topic in our database, so expertise assessment may not be accurate.
  2. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);